|
Feb 9
|
Hofseth Biocare ASA: FOURTH QUARTER 2023 AND FULL YEAR FINANCIAL REPORT
|
|
Feb 6
|
Hofseth Biocare ASA: HBC Immunology Inc successfully completes first animal model of prostate cancer with FT-005 in combination with hormonal (anti-androgen) therapy demonstrating significant anti-tumour activity
|
|
Jan 9
|
Hofseth Biocare ASA: SHARE CAPITAL INCREASE REGISTERED
|
|
Nov 27
|
Hofseth Biocare ASA: DISCLOSURE OF LARGE SHAREHOLDING
|
|
Nov 27
|
Hofseth Biocare ASA: MANDATORY NOTIFICATION OF TRADE
|